Los Angeles : Norris Comprehensive Cancer Center Updated
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Berlin : Vivantes Klinikum am Urban
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
Essen : Universitatsklinikum Essen
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
Hamburg : Universitatsklinikum Hamburg-Eppendorf
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
Hannover : Hannover Medical School
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
Kiel : Universitatsklinikum Schieswig-Holstein - Campus Kiel
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
View More »
Marburg : Universitatsklinikum Marburg
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
München : Klinikum Harlaching München
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
Tübingen : Universitatsklinikum der Eberhard-Karls-Universitat Tübingen
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer